Status
Conditions
Treatments
About
Blood culture samples from bacteremia patients positive for Gram-negative bacteria will be tested for antibacterial susceptibility using Resistell Phenotech device. The results will be compared with current AST gold standard tests to calculate sensitivity, specificity, and accuracy of Resistell Phenotech device.
Full description
NANO-RAST: Nano-motion based Resistell AST to determine the antibiotic susceptibility of bacteria causing bacteremia and sepsis.
Study population: patients admitted at the study site with bacteremia considered to be due to a pathogenic strain (E. coli or K. pneumoniae).
Study design: prospective, observational, single arm study.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria: The patients meeting all the following criteria can be recruited in the study:
Exclusion Criteria The patients meeting any of the following criteria will be excluded from the study:
Note: in the event that the capacity of the Resistell instruments is reached for the day, no more ICFs will be obtained for the day.
Loading...
Central trial contact
Danuta Cichocka, Dr; Clara Orlando, Dr
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal